Application of concurrent chemoradiotherapy in the treatment of non-operative esophageal cancer
10.3760/cma.j.issn.1008-6706.2019.06.033
- VernacularTitle:同期放化疗在非手术食管癌治疗中的应用
- Author:
Jian ZHANG
1
;
Ruiwen CHEN
Author Information
1. 蚌埠医学院研究生院 233000
- Keywords:
Esophageal neoplasms;
Molecular targeted therapy;
Chemoradiotherapy;
Hemibody irradi-ation;
Radiotherapy,intensity－modulated
- From:
Chinese Journal of Primary Medicine and Pharmacy
2019;25(6):762-768
- CountryChina
- Language:Chinese
-
Abstract:
Esophageal cancer is one of the most common malignant tumors of upper digestive tract.Squamous cell carcinoma dominates in China and other parts of Asia,while adenocarcinoma dominates in Europe and the United States.Therefore,there are great differences in the pathogenesis of its biological characteristics and the selection of relevant treatment methods.Currently,surgery is still the preferred method for patients with esophageal cancer.But for patients locally advanced or distant metastases who are inoperable and for patients who are operable but do not want surgery,concurrent chemotherapy with radiotherapy is considered the standard noninvasive treatment.
